Cargando…
Burkitt Lymphoma: Pathogenesis and Immune Evasion
B-cell lymphomas arise at distinct stages of cellular development and maturation, potentially influencing antigen (Ag) presentation and T-cell recognition. Burkitt lymphoma (BL) is a highly malignant B-cell tumor associated with Epstein-Barr Virus (EBV) infection. Although BL can be effectively trea...
Autores principales: | God, Jason M., Haque, Azizul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952908/ https://www.ncbi.nlm.nih.gov/pubmed/20953370 http://dx.doi.org/10.1155/2010/516047 |
Ejemplares similares
-
Multiple Defects Impair the HLA Class II Antigen Presentation Capacity of Burkitt Lymphoma
por: God, Jason M., et al.
Publicado: (2016) -
HLA Class II Defects in Burkitt Lymphoma: Bryostatin-1-Induced 17 kDa Protein Restores CD4+ T-Cell Recognition
por: Hossain, Azim, et al.
Publicado: (2011) -
The role of EBV in the pathogenesis of Burkitt’s Lymphoma: an Italian hospital based survey
por: Pannone, Giuseppe, et al.
Publicado: (2014) -
A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal
por: van den Bosch, Corry
Publicado: (2012) -
Lymphoma: Immune Evasion Strategies
por: Upadhyay, Ranjan, et al.
Publicado: (2015)